Background-While high doses of caffeine may affect pulmonary function
and bronchial challenge tests in patients with mild asthma, the effect
s of lower doses (less-than-or-equal-to 5 mg/kg) are less well documen
ted. Specific recommendations exist for withholding theophylline, but
not caffeine, before bronchoprovocation and pulmonary function testing
. Methods-To assess the effect of a single oral dose of caffeine (5 mg
/kg) on FEV1 and bronchial responsiveness to histamine a double blind,
placebo controlled study was performed in eight patients with mild st
able asthma. Results-While caffeine had no effect on FEV1, mean (95% c
onfidence interval) log PC20 histamine was significantly higher 150 mi
nutes [caffeine = 0.99 (0.2) mg/ml, placebo = 0.53 (0.29)] and 240 min
utes [caffeine = 0.89 (0.24), placebo = 0.44 (0.26)] after administrat
ion of caffeine than after placebo. Conclusions-Caffeine should be exc
luded from the diet for a period of more than four hours before bronch
ial provocation testing. The exact length of time for which it must be
excluded requires further study.